Send to a Friend Font Size: Increase Decrease

RO and NRIX Related Headlines

Jun 8, 2026 01:00AM Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

RO and NRIX Related Press Releases

Jun 8, 2026 01:00AM Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

RO and NRIX Related SEC Filings